Onsdag 30 Juli | 17:51:41 Europe / Stockholm

Kalender

Est. tid*
2026-01-10 N/A Årsstämma
2025-11-30 N/A Bokslutskommuniké 2025
2025-07-17 - Kvartalsrapport 2025-Q3
2025-04-17 - Kvartalsrapport 2025-Q2
2025-02-19 - Kvartalsrapport 2025-Q1
2025-02-03 - X-dag ordinarie utdelning CSMED 0.00 DKK
2025-01-31 - Årsstämma
2025-01-09 - 15-6 2025
2024-11-30 - Bokslutskommuniké 2024
2024-11-12 - Extra Bolagsstämma 2024
2024-08-15 - Kvartalsrapport 2024-Q3
2024-05-30 - Årsstämma
2024-05-17 - Kvartalsrapport 2024-Q2
2024-03-01 - X-dag ordinarie utdelning CSMED 0.00 DKK
2024-02-14 - Bokslutskommuniké 2023
2024-02-14 - Kvartalsrapport 2024-Q1
2023-12-15 - X-dag ordinarie utdelning CSMED 0.00 DKK
2023-07-18 - Kvartalsrapport 2023-Q3
2023-05-17 - Kvartalsrapport 2023-Q2
2023-04-14 - Extra Bolagsstämma 2023
2023-02-17 - Kvartalsrapport 2023-Q1
2023-02-14 - Årsstämma
2023-02-10 - X-dag ordinarie utdelning CSMED 0.00 DKK
2022-11-18 - Bokslutskommuniké 2022
2022-08-13 - Kvartalsrapport 2022-Q3
2022-05-20 - Kvartalsrapport 2022-Q2
2022-02-18 - Kvartalsrapport 2022-Q1
2021-12-10 - X-dag ordinarie utdelning CSMED 0.00 DKK
2021-12-09 - Årsstämma
2021-11-18 - Bokslutskommuniké 2021

Beskrivning

LandDanmark
SektorHälsovård
IndustriLäkemedel & Handel
CS Medica är ett danskt medicintekniskt bolag, dedikerat till läkemedelsforskning, utveckling, tillverkning och global kommersialisering. Bolaget blandar vetenskap och natur för att förbättra patienters liv med cannabinoidterapier för smärtlindring, och för att hantera autoimmuna och stressrelaterade symtom. Globalt erbjuder CS Medica CBD-behandlingar över disk (OTC), inklusive patenterade medicinska produkter, MHRA och MDR-registrerade artiklar, under varumärket CANNASEN® eller med egen märkning.
2022-09-29 14:53:03

CS MEDICA A/S ("CS MEDICA" or the "Company") announces that the Company has received orders for several Balkan countries. The full Cannasen® portfolio will be shipped to the countries to kick start the sales immediately. 

Lone Henriksen, CEO CS MEDICA, comments

"CS MEDICA are happy to announce that we found a strong partner, with the right strategy in place, to kick start sales in several Balkan countries. We see this as an opportunity to step into a region, not easily accessible without the know-how in the market. Also, this as an option to further develop the Balkan and Eastern EU presence in near future."

Mrzlica d.o.o. is a group of companies (real estate, construction, wholesale, trading, leasing and action house) , with more than 25 years' experience in international trading. Jadran Trend d.o.o., part of the Mrzlica d.o.o. group, have an extensive business network and partnership. Jadran Trend d.o.o. is responsible for online sales/advertisement and trading via whole sellers towards the pharmacies/drugstores.

"Unfortunately, we are not in a position to publish numbers in this PM due to competition reasons of our partner. Even so, this order does in fact help us a lot in reaching this year's revenue goal and the coming years", continous Lone Henriksen.

This disclosure contains information that CS MEDICA A/S is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 29-09-2022 14:53 CET.